Blog

CITATION: PD-L1/PD-1 Inhibitors and Beyond

A peer-reviewed article that appeared in the Journal of Pharmacology and Clinical Research by David Segarnick, PhD and Heather Chien, M.S., explores the current and future landscape of immunotherapy compounds that use the body’s own immune system to fight cancer. Literature data from Medmeme’s database is cited in tables throughout, to illustrate the Share of Scientific Voice among…

Read More

Strategic Metrics Dedicated to Medical Affairs

Metrics that bridge the gap to Medical Affairs 2.0 Historically, decisions for the generation and placement of Medical Affairs data were based on experience and instinct simply because hard, objective information was not available and end-to-end metrics for evaluation simply did not exist. In addition, finding the right thought leader to engage on behalf of…

Read More

PRESS: Harnessing the Unrivaled Power of Key Opinion Leaders

This month’s Pharmaceutical Market Europe Magazine features a thought leadership article from Medmeme.  The article discusses the importance of Medical Affairs engaging thought leaders and KOLs early  – not waiting until phase III trials – to drive Share of Scientific Voice and successful launches. It also goes on to talk about the importance of selecting the right KOLs…

Read More

Are You Being Heard? Part 2

Choosing the Best Options for Publishing and Presenting Your Research As previously discussed in the last post, rather than rely on the historical performance of a particular journal, it is now possible to measure a  broad continuum of current coverage of your topic– efficacy of a new drug, for example – and find the right…

Read More

Are You Being Heard? Part 1

An Increasingly Crowded World of Scientific Dissemination Is it better for your scientific paper to appear in JAMA or the New England Journal of Medicine? Should you present your research at a specialty meeting like the Annual Meeting of the Society for Immunotherapy of Cancer or choose a more general conference like the American Society…

Read More

Never Gonna Give You Up

Left High and Dry by Other Scientific Expert Data Providers?   One thing that data providers are quickly finding out is that maintaining complete, compliant and updated information on Scientific Experts is hard, especially at an enterprise level for a Medical Affairs organization. Medmeme is dedicated to the Medical Affairs community and has been collecting,…

Read More

Medical Affairs 2.0: It’s Time to Adapt…or Become Irrelevant

  “When you look at the big picture, you realize you either change and adapt or, as a species, you go extinct.” — Kenyan paleontologist and anthropologist Louise Leakey.   The need to adapt and evolve is as imperative for professions as it is for species. Particularly in rapidly changing environments like healthcare, strategies and…

Read More

We’re Hiring! Business Development Directors

Come and join our growing team. Medmeme partners with the world’s top pharmaceutical companies, delivering global data and analytics that power the sharing and dissemination of the world’s medical and scientific knowledge.  We have experienced significant growth year over year and need talented professionals like yourself to scale our ambitions further. Medmeme is hiring multiple Business Development Directors…

Read More

We’re Hiring! – Creative Director

Come and join our growing team. Medmeme partners with the world’s top pharmaceutical companies, delivering global data and analytics that power the sharing and dissemination of the world’s medical and scientific knowledge.  We have experienced significant growth year over year and need talented professionals like yourself to scale our ambitions further. Medmeme is hiring a Creative Director…

Read More

PRESS: A World of Content, In Context

Medmeme has been featured this week in GEN – Genetic Engineering and Biotechnology News! It is an in-depth interview with Medmeme’s CEO, Mahesh Naithani, who describes the particular challenges the pharmaceutical industry has in terms of accessing the right data, the unique ability of our data and products to meet those challenges, and where Medmeme is goes…

Read More